Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.910
-0.070 (-3.54%)
At close: Jun 8, 2026, 4:00 PM EDT
1.942
+0.032 (1.65%)
After-hours: Jun 8, 2026, 7:52 PM EDT
Fate Therapeutics Market Cap
Fate Therapeutics has a market cap or net worth of $222.63 million as of June 8, 2026. Its market cap has increased by 66.02% in one year.
Market Cap
222.63M
Enterprise Value
124.59M
1-Year Change
66.02%
Ranking
Category
Stock Price
$1.91
Market Cap Chart
Since October 1, 2013, Fate Therapeutics's market cap has increased from $126.10M to $222.63M, an increase of 76.55%. That is a compound annual growth rate of 4.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 230.80M | 103.53% |
| Dec 31, 2025 | 113.40M | -39.65% |
| Dec 31, 2024 | 187.90M | -49.05% |
| Dec 29, 2023 | 368.80M | -62.38% |
| Dec 30, 2022 | 980.40M | -82.45% |
| Dec 31, 2021 | 5.59B | -29.57% |
| Dec 31, 2020 | 7.93B | 436.27% |
| Dec 31, 2019 | 1.48B | 78.70% |
| Dec 31, 2018 | 827.80M | 225.01% |
| Dec 29, 2017 | 254.70M | 197.20% |
| Dec 30, 2016 | 85.70M | -11.47% |
| Dec 31, 2015 | 96.80M | -6.47% |
| Dec 31, 2014 | 103.50M | -19.01% |
| Dec 31, 2013 | 127.80M | 1.35% |
| Oct 1, 2013 | 126.10M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anavex Life Sciences | 238.17M |
| SAB Biotherapeutics | 237.53M |
| Protara Therapeutics | 233.81M |
| Orchestra BioMed Holdings | 233.53M |
| Codexis | 232.70M |
| Minerva Neurosciences | 231.08M |
| Entrada Therapeutics | 229.53M |
| Coherus Oncology | 223.66M |